HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 183 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,961,598 | -0.7% | 6,132,487 | +6.6% | 0.01% | 0.0% |
| Q2 2023 | $202,359,321 | +25.0% | 5,750,478 | +15.9% | 0.01% | +20.0% |
| Q1 2023 | $161,948,571 | -39.6% | 4,960,140 | +1.9% | 0.01% | -37.5% |
| Q4 2022 | $268,324,989 | +26.2% | 4,869,782 | +1.4% | 0.01% | +14.3% |
| Q3 2022 | $212,685,000 | +9.8% | 4,802,113 | +20.9% | 0.01% | +16.7% |
| Q2 2022 | $193,756,000 | +3.9% | 3,972,879 | +3.7% | 0.01% | +20.0% |
| Q1 2022 | $186,470,000 | +16.9% | 3,832,919 | +2.5% | 0.01% | +25.0% |
| Q4 2021 | $159,463,000 | +157.7% | 3,739,766 | +131.7% | 0.00% | +100.0% |
| Q3 2021 | $61,873,000 | +68.0% | 1,614,173 | +23.7% | 0.00% | +100.0% |
| Q2 2021 | $36,834,000 | +273.6% | 1,304,745 | +337.2% | 0.00% | – |
| Q1 2021 | $9,860,000 | -4.5% | 298,456 | +4.5% | 0.00% | – |
| Q4 2020 | $10,322,000 | +213.3% | 285,561 | +193.8% | 0.00% | – |
| Q3 2020 | $3,295,000 | – | 97,203 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |